Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.3800
+0.0162 (4.45%)
Jun 6, 2025, 2:38 PM - Market open
Applied Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 50.76 | 79.4 | 49.9 | 16.66 | 53.89 | 57.47 | Upgrade
|
| Short-Term Investments | - | - | - | 13.92 | 26.94 | 39.36 | Upgrade
|
| Cash & Short-Term Investments | 50.76 | 79.4 | 49.9 | 30.58 | 80.82 | 96.83 | Upgrade
|
| Cash Growth | -65.35% | 59.12% | 63.17% | -62.16% | -16.53% | 149.21% | Upgrade
|
| Other Receivables | - | - | - | 0.28 | 0.53 | 0.51 | Upgrade
|
| Receivables | - | - | - | 0.28 | 0.53 | 0.51 | Upgrade
|
| Prepaid Expenses | 1.26 | 1.74 | 1.35 | 2.12 | 2.56 | 2.91 | Upgrade
|
| Other Current Assets | 1.95 | 2.51 | 3.13 | 4.33 | 4.48 | 2.35 | Upgrade
|
| Total Current Assets | 53.97 | 83.65 | 54.39 | 37.31 | 88.39 | 102.59 | Upgrade
|
| Property, Plant & Equipment | 2.69 | 2.79 | 0.45 | 0.86 | 1.3 | 1.71 | Upgrade
|
| Other Long-Term Assets | 0.25 | 0.25 | - | 0.2 | 0.2 | 0.2 | Upgrade
|
| Total Assets | 56.91 | 86.69 | 54.83 | 38.36 | 89.89 | 104.51 | Upgrade
|
| Accounts Payable | 4.87 | 4.43 | 1.74 | 4.53 | 9.46 | 0.64 | Upgrade
|
| Accrued Expenses | 8.81 | 15.33 | 13.93 | 13.65 | 14.78 | 18.56 | Upgrade
|
| Short-Term Debt | - | - | 0.31 | 0.62 | 0.79 | 1.07 | Upgrade
|
| Current Portion of Leases | 0.43 | 0.41 | 0.43 | 0.48 | 0.44 | 0.41 | Upgrade
|
| Current Unearned Revenue | 0.21 | 0.21 | 0.67 | - | - | - | Upgrade
|
| Other Current Liabilities | 3.65 | 6.92 | 54.1 | 14.14 | 0.99 | 0.55 | Upgrade
|
| Total Current Liabilities | 17.97 | 27.3 | 71.18 | 33.42 | 26.46 | 21.24 | Upgrade
|
| Long-Term Leases | 2.27 | 2.39 | 0.04 | 0.41 | 0.89 | 1.33 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.76 | 0.46 | - | - | Upgrade
|
| Total Liabilities | 20.24 | 29.69 | 71.98 | 34.3 | 27.35 | 22.57 | Upgrade
|
| Common Stock | 0.04 | 0.04 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 632.67 | 631.18 | 451.43 | 352.83 | 328.96 | 242.78 | Upgrade
|
| Retained Earnings | -596.04 | -574.21 | -468.59 | -348.82 | -266.32 | -160.73 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 0.05 | -0.11 | -0.11 | Upgrade
|
| Total Common Equity | 36.67 | 57.01 | -17.15 | 4.06 | 62.54 | 81.94 | Upgrade
|
| Shareholders' Equity | 36.67 | 57.01 | -17.15 | 4.06 | 62.54 | 81.94 | Upgrade
|
| Total Liabilities & Equity | 56.91 | 86.69 | 54.83 | 38.36 | 89.89 | 104.51 | Upgrade
|
| Total Debt | 2.7 | 2.8 | 0.78 | 1.51 | 2.12 | 2.81 | Upgrade
|
| Net Cash (Debt) | 48.06 | 76.6 | 49.12 | 29.07 | 78.7 | 94.02 | Upgrade
|
| Net Cash Growth | -67.11% | 55.95% | 68.99% | -63.07% | -16.29% | 155.38% | Upgrade
|
| Net Cash Per Share | 0.33 | 0.55 | 0.58 | 0.77 | 3.07 | 4.28 | Upgrade
|
| Filing Date Shares Outstanding | 141.58 | 141.58 | 105.89 | 48.11 | 26.22 | 26.01 | Upgrade
|
| Total Common Shares Outstanding | 141.58 | 137.23 | 84.87 | 48.06 | 26.22 | 22.49 | Upgrade
|
| Working Capital | 36 | 56.35 | -16.8 | 3.88 | 61.93 | 81.36 | Upgrade
|
| Book Value Per Share | 0.26 | 0.42 | -0.20 | 0.08 | 2.39 | 3.64 | Upgrade
|
| Tangible Book Value | 36.67 | 57.01 | -17.15 | 4.06 | 62.54 | 81.94 | Upgrade
|
| Tangible Book Value Per Share | 0.26 | 0.42 | -0.20 | 0.08 | 2.39 | 3.64 | Upgrade
|
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.